When Americans begin taking appetite-suppressing drugs like Ozempic and Wegovy, the changes extend well beyond the bathroom scale. According to new research, the medications are associated with meaningful reductions in how much households spend on food, both at the grocery store and at restaurants.The study, published Dec. 18 in the Journal of Marketing Research, links survey data on GLP-1 receptor agonist use – a class of drugs originally developed for diabetes and now widely prescribed for wei...